FDA Grants Approval for Nitrogycerin ANDA214565 by Padagis Israel
The FDA has granted approval for the ANDA214565 application for Nitrogycerin submitted by Padagis Israel.
Asset / Drug
Drug and asset intelligence for Nitroglycerin with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.